… Guide to Digitizing Cell and Gene Therapy Manufacturing” for strategies that … management, especially for cell and gene therapy developers. By embracing its principle … Guide to Digitizing Cell and Gene Therapy Manufacturing,” MasterControl, 2025. “Novartis …

Gene editing startup Metagenomi has tapped AWS's Inferentia 2 accelerators to speed the discovery of potentially life-saving therapies, and said its efforts cost 56 percent less than it would have incurred using Nvidia GPUs. Founded in 2018, Metagenomi …

… winding down its cell and gene therapy (CGT) division after an unsuccessful …

… and stem cell derived products, gene therapy products, modified release dosage forms …

… the predominant viral vector in gene therapy, with recent funding trends favoring …

… and preliminary efficacy of investigational gene therapy AB-1002 in participants … one-time administration of investigational gene therapy AB-1002, via antegrade … a fully integrated gene therapy company dedicated to steering gene therapy into a new …

… (enekinragene inzadenovec), a novel gene therapy candidate for osteoarthritis of the … -Capacity Adenovirus Serotype 5 Gene Therapy Demonstrates Sustained Clinical Efficacy … capacity adenovirus (HCAd) vector gene therapy vector platform. This platform solves …

… deafness, the toddler received a gene therapy developed by Regeneron Pharmaceuticals Inc … the potential of Regeneron’s gene therapy. Even more encouraging, its findings … . Yet unlike with implants, the gene therapy provides children with hearing that …

… million. He celebrated a recent gene therapy trial for hemophilia — conducted in … successful indigenous clinical trial in gene therapy. The Minister underscored the role …